Lb Pharmaceuticals INC (LBRX) SEC Filings — 2026
4 SEC filings for Lb Pharmaceuticals INC (LBRX) in 2026.
Filings
- Lb Pharmaceuticals INC ARS Filing — ARS · Apr 23, 2026
- LB Pharmaceuticals Files Definitive Proxy Statement — DEFA14A · Apr 23, 2026
- Lb Pharmaceuticals INC EFFECT Filing — EFFECT · Apr 15, 2026
- LB Pharmaceuticals Advances Schizophrenia Drug to Phase 3, Targets $12B Market — 10-K · Mar 26, 2026